Predicting Outcome in Guillain-Barré Syndrome
Alex Y. Doets(Erasmus University Rotterdam), Fábio Barroso(Université Paris-Sud), Girolama Alessandra Marfia(Erasmus University Rotterdam), Satoshi Kuwabara(Chiba University), Luís Querol(Hospital de Sant Pau), Søren H. Sindrup(University of Southern Denmark), Volkan Granit(Biohaven Pharmaceuticals (United States)), Angelo Schenone(University of Genoa), Luana Benedetti, Waqar Waheed(Erasmus MC), Nowshin Papri(Erasmus University Rotterdam), Soledad Monges(Erasmus MC), J. Marín Pardo(Erasmus University Rotterdam), Hester F. Lingsma(Erasmus MC), R. P. Kleyweg(Albert Schweitzer Ziekenhuis), Krista Kuitwaard(Erasmus MC), Eduardo Nobile‐Orazio(Humanitas University), Susumu Kusunoki(Japan Association for Development of Community Medicine), Sonja E. Leonhard(Erasmus MC), Amy Davidson(Erasmus MC), Yuko Yamagishi(Erasmus University Rotterdam), Helmar C. Lehmann(University Hospital Cologne), Isabel Illa(Hospital de Sant Pau), Kathleen Bateman, Yann Péréon(European Organisation for Rare Diseases), Mazen M. Dimachkie(University of Kansas Medical Center), J. Bürmann(Erasmus University Rotterdam), Peter Van den Bergh(Cliniques Universitaires Saint-Luc), Simon Rinaldi(Erasmus University Rotterdam), Giuliana Galassi(Erasmus MC), María J. Sedano Tous(Erasmus University Rotterdam), Frédérique H Vermeij(Sint Franciscus Gasthuis), Govindsinh Chavada, Christa Walgaard(Erasmus MC), Thomas Harbo(Erasmus MC), Guido Cavaletti(Bellvitge University Hospital), Noah Kolb(University of Vermont Medical Center), Quazi Deen Mohammad, James Miller(Royal Victoria Infirmary), Zhahirul Islam, Joyce Roodbol, Nortina Shahrizaila(Erasmus MC), Yuzhong Wang(Wuxi Third People's Hospital), Christine Verboon(Erasmus MC), Cintia Marchesoni(Erasmus University Rotterdam), Bianca van den Berg(Erasmus MC), Carlos Casasnovas(Erasmus MC), Hugh J. Willison(University of Glasgow), Badrul Islam(Erasmus University Rotterdam), Gerardo Gutiérrez‐Gutiérrez(Erasmus University Rotterdam)
Cited by 67
Related Papers
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
|Annals of Neurology|2010|728
Symptomatology and Functional Outcome in Mild Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study
|Journal of Neurotrauma|2013|517